ORKA
Oruka Therapeutics, Inc.
+0.98 (+1.05%)94.53USD183K成交股數6.3B市值21.3本益比(近四季)–股價營收比–營收年增(近四季)2026-11-11下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | 0.00 | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 43.3M | 29.1M | 27.6M | 29.0M | 24.1M | 19.9M | 25.7M | 18.7M | 5.2M | – | 322K | 254K |
| 銷售管理費用 | 6.9M | 7.3M | 6.8M | 5.1M | 4.3M | 5.2M | 3.8M | 2.8M | 1.7M | – | 1.6M | 1.7M |
| 營業利益 | −50.1M+76% | −36.4M+45% | −34.4M+17% | −34.1M+59% | −28.4M+314% | −25.1M | −29.4M+1420% | −21.5M+989% | −6.9M | – | −1.9M | −2.0M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −41.2M+68% | −31.8M+52% | −29.6M+3% | −30.3M+36% | −24.6M+247% | −21.0M+1828% | −28.6M+1910% | −22.2M+1403% | −7.1M | −1.1M | −1.4M | −1.5M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | – | – | – | – | -0.46-79% | -0.40 | -1.46+1360% | -6.96+6860% | -2.21 | – | -0.10 | -0.10 |
| 稀釋股數 | – | – | – | – | 42.1M | 41.7M | 15.0M | 3.2M | 3.2M | – | 14.4M | 14.4M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 268M | 49.5M | 46.9M | 91.3M | 65.4M | 83.6M | 411M | 33.3M | 35.9M | 37.4M | 38.5M | 40.2M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 1.1B | 504M | 489M | 509M | 357M | 377M | 414M | 33.8M | 36.7M | 37.9M | 39.2M | 41.1M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 24.8M | 17.8M | 16.7M | 22.5M | 13.8M | 12.4M | 18.9M | 1.3M | 1.6M | 841K | 1.2M | 1.8M |
| 股東權益 | 1.1B | 487M | 472M | 487M | 344M | 365M | 342M | −29.0M | −7.1M | 37.0M | 38.0M | 39.2M |
| 負債比 | 2.2% | 3.5% | 3.4% | 4.4% | 3.9% | 3.3% | 4.6% | 3.8% | 4.3% | 2.2% | 3.1% | 4.5% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −23.6M+13% | – | – | – | −20.9M | – | – | −168K | – | – | – |
| 資本支出 | – | 73K | – | – | – | 13K | – | – | – | – | – | – |
| 自由現金流 | – | −23.7M+13% | – | – | – | −20.9M | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | 3K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −105M | –% | – | −88.4M |
| FY2024 | – | – | −83.7M | –% | -3.87 | −58.0M |
| FY2023 | 0.00 | – | −5.3M | –% | -0.37 | −5.0M |
| FY2022 | 0.00 | – | −9.9M | –% | -0.69 | −10.9M |
| FY2021 | 0.00 | – | −19.3M | –% | -1.39 | −18.8M |
| FY2020 | 0.00 | – | −9.7M | –% | -2.07 | −7.7M |
| FY2019 | 0.00 | – | −5.5M | –% | -4.15 | −4.8M |
| FY2018 | 0.00 | – | −7.9M | –% | -10.31 | −8.2M |